Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-03-12 @ 1:49 AM
Study NCT ID:
NCT00794066
Status:
COMPLETED
Last Update Posted:
2017-10-25
First Post:
2008-11-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Peripheral Arteriopathy Rate In Stroke
Sponsor:
University of Erlangen-Nürnberg Medical School
Organization:
Study Overview
Official Title:
Prevalence of Peripheral Arterial Disease in Acute Ischemic and Hemorrhagic Stroke Patients
Status:
COMPLETED
Status Verified Date:
2017-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PARIS
Brief Summary:
Purpose:
To assess the prevalence of peripheral arterial disease (PAD) in acute stroke patients.
Interventions:
Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).
Design:
Prospective, open, cohort study.
Study size planned:
1500\.
Follow-up duration:
3 months.
To assess the prevalence of peripheral arterial disease (PAD) in acute stroke patients.
Interventions:
Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).
Design:
Prospective, open, cohort study.
Study size planned:
1500\.
Follow-up duration:
3 months.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: